Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues
<p>Abstract</p> <p>The Hepatitis B virus (HBV) is a DNA virus that can cause both acute and chronic liver disease in humans. Approximately 350-400 million people are affected worldwide and up to one million deaths occur annually from cirrhosis and hepatocellular carcinoma. When cir...
Saved in:
Main Authors: | Schiff Eugene R (Author), Schreibman Ian R (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2006-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group
by: Xiaojun Sun, et al.
Published: (2020) -
Current prodrug strategies for improving oral absorption of nucleoside analogues
by: Youxi Zhang, et al.
Published: (2014) -
Milestones in the discovery of antiviral agents: nucleosides and nucleotides
by: Erik de Clercq
Published: (2012) -
Profile of Nucleotides and Nucleosides in Taiwanese Human Milk
by: Kuo-Yu Liao, et al.
Published: (2011) -
Custo-efetividade dos análogos de nucleosídeos/nucleotídeos para hepatite crônica B Costo-efectividad de los análogos de nucleósidos/nucleótidos para hepatitis crónica B Cost-effectiveness of nucleoside/nucleotide analogues in chronic hepatitis B
by: Alessandra Maciel Almeida, et al.
Published: (2012)